GlassScriptPhysician profile
Sabreen Ahmed
NPI 1821452749
$10,126.77
in general payments reported to CMS, 2019-2025
47 companies · $2,441 in 2025
The $2,441 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.17 · 2021: $46.92 · 2022: $2,348 · 2023: $2,618 · 2024: $2,658 · 2025: $2,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,706 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,705.69 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,533.06 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,403.79 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $836.62 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Corcept Therapeutics | $672.30 | 2022-2025 | Korlym |
| Cequr Corporation | $663.06 | 2022-2025 | Cequr Simplicity |
| Amneal Pharmaceuticals LLC | $642.13 | 2022-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $562.77 | 2022-2025 | |
| Radius Health, INC. | $341.65 | 2023-2025 | Tymlos |
| Insulet Corporation | $302.19 | 2022-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $276.54 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $259.33 | 2022-2025 | |
| Amgen INC. | $252.05 | 2022-2025 | Evenity, Prolia, Prolia |
| Astrazeneca Pharmaceuticals LP | $229.22 | 2021-2023 | Farxiga |
| Abbvie INC. | $205.15 | 2022-2025 | |
| Abbott Laboratories | $202.67 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.05 | 2022-2025 | Jardiance |
| Antares Pharma, INC. | $156.63 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Recordati_rare_diseases_inc. | $152.20 | 2022-2025 | Isturisa, Signifor Lar |
| Amphastar Pharmaceuticals, INC. | $122.02 | 2025 | |
| Medtronic, INC. | $108.26 | 2022-2024 | Minimed 780g |
| Madrigal Pharmaceuticals | $106.91 | 2025 | Rezdiffra |
| Alexion Pharmaceuticals, INC. | $95.41 | 2023-2024 | Strensiq |
| Tolmar, INC. | $67.29 | 2023-2025 | Jatenzo |
| Dexcom, INC. | $67.03 | 2024-2025 | Dexcom G6 Transmitter |
| Ascensia Diabetes Care US INC. | $66.64 | 2023 | |
| Acella Pharmaceuticals, LLC | $49.74 | 2024-2025 | NP Thyroid 60 |
| Kyowa Kirin, INC. | $44.75 | 2023 | Crysvita |
| Lifescan, INC. | $42.86 | 2022 | |
| Halozyme INC | $42.25 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $40.89 | 2023 | |
| Astellas Pharma US INC | $38.79 | 2023 | Veozah, Myrbetriq |
| Amryt Pharma Holdings LTD | $34.68 | 2022-2023 | Mycapssa |
| Sandoz INC. | $31.80 | 2024 | |
| Becton, Dickinson and Company | $31.25 | 2022 | |
| Boston Scientific Corporation | $28.04 | 2025 | Wavewriter Alpha Prime 16 |
| Embecta Corp. | $27.44 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Beta Bionics, INC. | $26.83 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sequel Med Tech, LLC | $26.52 | 2025 | Twiist |
| Baxter Healthcare | $25.05 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Eusa Pharma (US) LLC | $21.20 | 2022 | |
| Nevro Corp. | $21.14 | 2022 | |
| Neurocrine Biosciences, INC. | $20.58 | 2024 | |
| Mannkind Corporation | $19.65 | 2022 | |
| Ibsa Pharma INC. | $15.97 | 2022 | |
| Merck Sharp & Dohme LLC | $15.76 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.44 | 2025 | Azmiro |
| E.R. Squibb & Sons, L.L.C. | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabreen Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.